A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Procaterol
Estradiol cypionate
Estradiol cypionate may decrease the anticoagulant activities of Sodium citrate.
Procaterol
Estradiol benzoate
Estradiol benzoate may decrease the anticoagulant activities of Sodium citrate.
Procaterol
Estradiol acetate
Estradiol acetate may decrease the anticoagulant activities of Sodium citrate.
Procaterol
Moxestrol
Moxestrol may decrease the anticoagulant activities of Sodium citrate.
Procaterol
Epimestrol
Epimestrol may decrease the anticoagulant activities of Sodium citrate.
Procaterol
Methallenestril
Methallenestril may decrease the anticoagulant activities of Sodium citrate.
Procaterol
Equol
Equol may decrease the anticoagulant activities of Sodium citrate.
Procaterol
Zeranol
Zeranol may decrease the anticoagulant activities of Sodium citrate.
Procaterol
Esterified estrogens
Esterified estrogens may decrease the anticoagulant activities of Sodium citrate.
Procaterol
Polyestradiol phosphate
Polyestradiol phosphate may decrease the anticoagulant activities of Sodium citrate.
Procaterol
Synthetic Conjugated Estrogens, B
Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Sodium citrate.
Procaterol
Synthetic Conjugated Estrogens, A
Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Sodium citrate.
Procaterol
Hexestrol
Hexestrol may decrease the anticoagulant activities of Sodium citrate.
Procaterol
Quinestrol
Quinestrol may decrease the anticoagulant activities of Sodium citrate.
Procaterol
Aluminum hydroxide
Sodium citrate can cause an increase in the absorption of Aluminum hydroxide resulting in an increased serum concentration and potentially a worsening of adverse effects.
Procaterol
Ginkgo biloba
The therapeutic efficacy of Sodium citrate can be increased when used in combination with Ginkgo biloba.
Procaterol
Tibolone
Tibolone may increase the anticoagulant activities of Sodium citrate.
Procaterol
Sugammadex
The risk or severity of bleeding and hemorrhage can be increased when Sodium citrate is combined with Sugammadex.
Procaterol
Obinutuzumab
The risk or severity of bleeding and hemorrhage can be increased when Sodium citrate is combined with Obinutuzumab.
Procaterol
Ibrutinib
The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Sodium citrate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3